Riskpilot← Back to searchSign inGet full accessAB Synalfa
ABActiveOrg 5566190962Rodga RyttartorpResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20010 employees
Revenue 2024
SEK 0
EBITDA margin
—
-348% vs 2023
Equity ratio
-927.6%
Financial strength
Net profit 2024
SEK -856K
-11684% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -21K | -348% |
| Net profit | SEK -856K | -11684% |
| Total assets | SEK 77K | -92% |
| Equity | SEK -713K | -599% |
| Employees | 0 | — |
Legal name
AB Synalfa
Org number
5566190962
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 november 2001
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utveckling av och handel med produkter och tjänster inom veterinärmedicin, hästavel samt därmed förenlig verksamhet.
Address
Rodga Ryttartorp
Phone
+461161493
Email
thorsten.darenius@agdor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 | 48 | 30 | 19 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 | 37 | 18 | 8 | −21 |
| Depreciation & amort. | −0 | −0 | — | — | −834 |
| EBIT | 7 | 37 | 18 | 8 | −855 |
| Net financials | −1 | −1 | −1 | −1 | −1 |
| Profit before tax | 6 | 36 | 17 | 7 | −856 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 6 | 36 | 17 | 7 | −856 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 874 | 917 | 930 | 936 | 77 |
| Equity | 82 | 118 | 135 | 143 | −713 |
| Long-term debt | 200 | 200 | 200 | 200 | 0 |
| Short-term debt | 592 | 599 | 594 | 593 | 790 |
| Total debt | 792 | 799 | 794 | 793 | 790 |
EBITDA margin
-2090700.0%
This company
15.8%
Market median
-13232378% vs market
20202024
Equity ratio
-927.6%
This company
38.2%
Market median
-2528% vs market
20202024
Return on equity
-85569000.0%
This company
18.4%
Market median
-465049013% vs market
20202024
Net profit margin
-85569000.0%
This company
8.1%
Market median
-1056407507% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KR Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2026 | |
| Deputy Board Member | 2026 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2025 – 2026 | |
| Deputy Board Member | 2025 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AB Synalfa 
Equibas AktiebolagBoard members of AB Synalfa also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Richard Anders Darenius | Chief Executive Officer | 0 companies |
| Kaj Nils Thorsten Darenius | Board of Directors | 0 companies |
| Birgitta Ligita Inara Helmsteins | Deputy Board Member | 0 companies |
| Ulla Elisabet Darenius | Board of Directors | 0 companies |
| Eva Helena Darenius Asp | Deputy Board Member | 0 companies |
| Emelie Dina Louise Darenius | Deputy Board Member | 0 companies |